Oral gabapentin to prevent postsurgical pai
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2019/02/017494
- Lead Sponsor
- SIBHA SD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA grade 1 &2
informed consent
Exclusion Criteria
patient refusal,
chronic pain syndrome,
known seizure/ psychiatric disorder,
drug abuse
already on gabapentin/ pregablin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to evaluate gabapentin when given orallyin the preoperative period at a dose of 300mg has an effect on postoperative pain and analgesic requirementsTimepoint: At various intervals of 0, 2, 6, 12, 24 hours postoperatively
- Secondary Outcome Measures
Name Time Method adverse events .Timepoint: 24hours postoperative period